plerixafor has been researched along with amd 8664 in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 3 (60.00) | 24.3611 |
| 2020's | 1 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bridger, GJ; Gerlach, LO; Hatse, S; Rosenkilde, MM; Schols, D; Schwartz, TW; Skerlj, RT | 1 |
| Boehringer, EM; Bogucki, DE; Bridger, GJ; Crawford, J; De Clercq, E; Hatse, S; Hernandez-Abad, PE; Metz, M; Nan, S; Princen, K; Schols, D; Skerlj, RT; Wang, Z; Wilson, T; Zhou, Y | 1 |
| Huang, B; Kang, D; Liu, N; Liu, X; Zhan, P; Zhang, H; Zhao, F | 1 |
| Cao, B; Long, YQ; Peng, D; Zhou, YJ | 1 |
| Dranchak, PK; Huang, R; Inglese, J; Lamy, L; Oliphant, E; Queme, B; Tao, D; Wang, Y; Xia, M | 1 |
2 review(s) available for plerixafor and amd 8664
| Article | Year |
|---|---|
Discovery of non-peptide small molecular CXCR4 antagonists as anti-HIV agents: Recent advances and future opportunities.
Topics: Anti-HIV Agents; Drug Discovery; HIV; Humans; Microbial Sensitivity Tests; Molecular Structure; Receptors, CXCR4; Small Molecule Libraries; Structure-Activity Relationship | 2016 |
The chemical diversity and structure-based evolution of non-peptide CXCR4 antagonists with diverse therapeutic potential.
Topics: Chemokine CXCL12; Drug Discovery; Drug Therapy; Humans; Ligands; Receptors, CXCR4 | 2018 |
3 other study(ies) available for plerixafor and amd 8664
| Article | Year |
|---|---|
Molecular mechanism of action of monocyclam versus bicyclam non-peptide antagonists in the CXCR4 chemokine receptor.
Topics: Amino Acid Sequence; Animals; Anti-HIV Agents; Antibodies, Monoclonal; Benzylamines; Chlorocebus aethiops; COS Cells; Cyclams; Heterocyclic Compounds; Humans; Molecular Sequence Data; Mutation; Pyridines; Receptors, CXCR4 | 2007 |
Synthesis and structure-activity relationships of azamacrocyclic C-X-C chemokine receptor 4 antagonists: analogues containing a single azamacrocyclic ring are potent inhibitors of T-cell tropic (X4) HIV-1 replication.
Topics: Anti-HIV Agents; Heterocyclic Compounds; HIV Infections; HIV-1; Humans; Models, Chemical; Molecular Structure; Pyridines; Receptors, CXCR4; Structure-Activity Relationship; T-Lymphocytes; Virus Replication | 2010 |
In vivo quantitative high-throughput screening for drug discovery and comparative toxicology.
Topics: Animals; Caenorhabditis elegans; Drug Discovery; High-Throughput Screening Assays; Humans; Proteomics; Small Molecule Libraries | 2023 |